PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Decrease in Short Interest

PureTech Health plc (OTCMKTS:PTCHF) was the target of a large decrease in short interest in August. As of August 15th, there was short interest totalling 24,700 shares, a decrease of 17.1% from the July 31st total of 29,800 shares. Based on an average daily volume of 18,700 shares, the days-to-cover ratio is presently 1.3 days.

PureTech Health Stock Performance

PureTech Health stock opened at $2.09 on Friday. The firm’s fifty day moving average price is $2.21 and its 200-day moving average price is $2.52. PureTech Health has a fifty-two week low of $1.69 and a fifty-two week high of $3.00.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.